How Viz.ai is harnessing AI to expedite lifesaving diagnoses Viz.ai uses algorithms to examine medical imagery and patient tests to detect critical conditions such as stroke or pulmonary embolism.
SAN FRANCISCO, January 30, 2025--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced an expanded partnership with Softek ...
SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data supporting advancements in neurovascular care.
Real-world evidence presented at the 2025 International Stroke Conference shows positive impact of AI-powered care coordination on stroke treatment times and financial outcomes Viz.ai, the leader ...
On November 27, Viz.ai, a company working on AI-powered disease detection and intelligent care coordination, announced that it would be partnering with Microsoft to deliver its AI models and care ...
Viz.ai, CrowdPharm and Remedy Product Studio discuss the potential of AI in pharma, from improving internal operations to enhancing patient treatment. There are fewer people on treatment plans ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果